Stoessl AJ - Search Results

1

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.

Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. Olanow CW, et al. Among authors: stoessl aj. Ann Neurol. 2003 Sep;54(3):403-14. doi: 10.1002/ana.10720. Ann Neurol. 2003. PMID: 12953276 Clinical Trial.

2

Positron emission tomography after fetal transplantation in Huntington's disease.

Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB, Freeman TB, Stoessl AJ. Furtado S, et al. Among authors: stoessl aj. Ann Neurol. 2005 Aug;58(2):331-7. doi: 10.1002/ana.20564. Ann Neurol. 2005. PMID: 16049929 Clinical Trial.

3

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.

Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Olanow CW, et al. Among authors: stoessl aj. Mov Disord. 2009 Feb 15;24(3):336-43. doi: 10.1002/mds.22208. Mov Disord. 2009. PMID: 19006186 Clinical Trial.

4

Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.

Kordower JH, Goetz CG, Chu Y, Halliday GM, Nicholson DA, Musial TF, Marmion DJ, Stoessl AJ, Sossi V, Freeman TB, Olanow CW. Kordower JH, et al. Among authors: stoessl aj. Ann Neurol. 2017 Jan;81(1):46-57. doi: 10.1002/ana.24820. Epub 2017 Jan 6. Ann Neurol. 2017. PMID: 27900791 Free PMC article.

5

Bilateral human fetal striatal transplantation in Huntington's disease.

Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, Scott D, Nauert GM, Soety E, Sossi V, Holt DA, Sanberg PR, Stoessl AJ, Freeman TB. Hauser RA, et al. Among authors: stoessl aj. Neurology. 2002 Mar 12;58(5):687-95. doi: 10.1212/wnl.58.5.687. Neurology. 2002. PMID: 11889229 Clinical Trial.

6

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.

Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ. Sossi V, et al. Among authors: stoessl aj. Ann Neurol. 2007 Nov;62(5):468-74. doi: 10.1002/ana.21204. Ann Neurol. 2007. PMID: 17886297

7

Advances in imaging in Parkinson's disease.

Stoessl AJ, Martin WW, McKeown MJ, Sossi V. Stoessl AJ, et al. Lancet Neurol. 2011 Nov;10(11):987-1001. doi: 10.1016/S1474-4422(11)70214-9. Lancet Neurol. 2011. PMID: 22014434 Review.

8

Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.

de la Fuente-Fernández R, Lu JQ, Sossi V, Jivan S, Schulzer M, Holden JE, Lee CS, Ruth TJ, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: stoessl aj. Ann Neurol. 2001 Mar;49(3):298-303. doi: 10.1002/ana.65.abs. Ann Neurol. 2001. PMID: 11261503

9

Progress in clinical neurosciences: a forum on the early management of Parkinson's disease.

Lang AE, Miyasaki J, Olanow CW, Stoessl AJ, Suchowersky O. Lang AE, et al. Among authors: stoessl aj. Can J Neurol Sci. 2005 Aug;32(3):277-86. doi: 10.1017/s0317167100004145. Can J Neurol Sci. 2005. PMID: 16225167 Review.

10

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, Stoessl AJ, Olanow CW, Bartus RT. Marks WJ Jr, et al. Among authors: stoessl aj. Lancet Neurol. 2008 May;7(5):400-8. doi: 10.1016/S1474-4422(08)70065-6. Epub 2008 Apr 2. Lancet Neurol. 2008. PMID: 18387850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page